Long-term remission with certolizumab pegol in Crohn's disease: Efficacy over 5 years in patients with no prior anti-TNF agent exposure (precise 3 study): P36.


    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.


    loading  Loading Related Articles